Cargando…

Comparison of the application of (18)F-FDG and (68)Ga-DOTATATE PET/CT in neuroendocrine tumors: A retrospective study

The present study aimed to compare the efficacy of (68)Ga-DOTATATE PET/CT and (18)F-FDG PET/CT imaging in the diagnosis, staging, and prognosis evaluation of neuroendocrine tumors (NET). A total of 55 patients (43 were initially evaluated, 12 were evaluated after treatment) who underwent fluorine-18...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xianwen, Li, Dandan, Wang, Rui, Wang, Pan, Cai, Jiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	4100
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174405/ https://www.ncbi.nlm.nih.gov/pubmed/37171344 http://dx.doi.org/10.1097/MD.0000000000033726

Ejemplares similares

Comparison of (18)F-FDG PET/CT imaging with different dual time (18)F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer
por: Yu, Longhua, et al.
Publicado: (2023)

Ovarian dysgerminoma detected by (18)F-FDG PET/CT technique: A case report
por: Wang, Peng, et al.
Publicado: (2020)

Clinical and Prognostic Value of PET/CT Imaging with Combination of (68)Ga-DOTATATE and (18)F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms
por: Zhang, Panpan, et al.
Publicado: (2018)

The Diagnostic and Grading Accuracy of (68)Ga-DOTATATE and (18)F-FDG PET/MR for Pancreatic Neuroendocrine Neoplasms
por: Zhou, Jinxin, et al.
Publicado: (2022)

(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity
por: Chang, Chian A., et al.
Publicado: (2016)

18F-FDG PET/CT in preoperative staging of vulvar cancer patients: is it really effective?
por: Crivellaro, Cinzia, et al.
Publicado: (2017)

Comparison of (18)F‐FDG PET/CT and (68)Ga‐DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia
por: Yu, Hao‐nan, et al.
Publicado: (2021)

Detection of Atherosclerotic Inflammation by (68)Ga-DOTATATE PET Compared to [(18)F]FDG PET Imaging
por: Tarkin, Jason M., et al.
Publicado: (2017)

(68)Ga-PSMA-11 PET/CT combining ADC value of MRI in the diagnosis of naive prostate cancer: Perspective of radiologist
por: Wang, Liwei, et al.
Publicado: (2020)

Prospective comparison of [(18)F]AlF-NOTA-octreotide PET/MRI to [(68)Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
por: Boeckxstaens, Lennert, et al.
Publicado: (2023)

Evaluation of Dual Time Point Imaging 18F-FDG PET/CT in Differentiating Malignancy From Benign Gastric Disease
por: Cui, Jing, et al.
Publicado: (2015)

Dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score
por: Chan, David L., et al.
Publicado: (2022)

Evaluation of (18)F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with (68)Ga-DOTATATE PET/CT
por: Hou, Jiale, et al.
Publicado: (2021)

Testicular Metastasis of Jejunal Neuroendocrine Tumor on (68)Ga-DOTATATE PET/CT
por: Şahin, Ömer Faruk, et al.
Publicado: (2023)

Pulmonary large cell neuroendocrine carcinoma (LCNEC) with confirmed liver metastases negative on (18)F-FDG and (68)Ga-DOTATATE PET
por: Ninatti, Gaia, et al.
Publicado: (2020)

Complementary role of (18)F-FDG and (68)Ga-DOTATATE PET/CT in the surveillance of patients with von Hippel-Lindau syndrome
por: Papadakis, Georgios Z., et al.
Publicado: (2020)

Ileal Neuroendocrin Tumor Metastasis to Breast Diagnosed with Ga-68 DOTATATE PET/CT
por: Sağlampınar Karyağar, Sevda, et al.
Publicado: (2019)

(18)F-FDG PET/CT for detection of the primary tumor in adults with extracervical metastases from cancer of unknown primary: A systematic review and meta-analysis
por: Burglin, Synne Alexandra, et al.
Publicado: (2017)

(68)Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with(18)F-FDG, calcium burden and risk factors
por: Li, Xiang, et al.
Publicado: (2012)

Molecular imaging of a glucagonoma with (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging: A case report and review of the literature
por: Fathala, Ahmed, et al.
Publicado: (2019)

Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT
por: Resch, Katrin, et al.
Publicado: (2022)

Widespread micronodular hepatic metastases of neuroendocrine tumor detected by [(68)Ga]DOTATATE PET/CT
por: D'Souza, Julia C., et al.
Publicado: (2022)

A new diagnostic marker for differentiating multicentric gliomas from multiple intracranial diffuse large B-cell lymphomas on (18)F-FDG PET images
por: Wang, Kai, et al.
Publicado: (2017)

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
por: Kunz, Wolfgang G., et al.
Publicado: (2018)

Diagnosing microscopic pancreatic neuroendocrine tumor using 68-Ga-DOTATATE PET/CT: case series
por: Barrio, Martin, et al.
Publicado: (2018)

Role of Combined (68)Ga DOTA-Peptides and (18)F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Kaewput, Chalermrat, et al.
Publicado: (2022)

Prognostic value of a three-scale grading system based on combining molecular imaging with (68)Ga-DOTATATE and (18)F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias
por: Karfis, Ioannis, et al.
Publicado: (2020)

Metastatic urinary bladder paraganglioma on Ga-68 DOTATATE PET/CT
por: Ko, Andrew, et al.
Publicado: (2021)

Comparison of (18)F-FDG PET/CT and (68)Ga-FAPI in Spindle Cell Rhabdomyosarcoma
por: Shen, Zhihui, et al.
Publicado: (2023)

The potential application of MR-derived ADCmin values from (68)Ga-DOTATATE and (18)F-FDG dual tracer PET/MR as replacements for FDG PET in assessment of grade and stage of pancreatic neuroendocrine tumors
por: Gao, Jing, et al.
Publicado: (2023)

Dual Tracer PET Imaging (68Ga-DOTATATE and 18F-FDG) Features in Pulmonary Carcinoid: Correlation with Tumor Proliferation Index
por: Bhatkar, Dhiraj, et al.
Publicado: (2017)

(68)Ga-PSMA PET/CT Versus (18)F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
por: Gündoğan, Cihan, et al.
Publicado: (2021)

Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [(68)Ga]Ga DOTATATE PET-CT
por: Bilen, Mehmet Asim, et al.
Publicado: (2022)

Intra-individual qualitative and quantitative comparison of [(68)Ga]Ga-DOTATATE PET/CT and PET/MRI
por: Lens, Géraldine, et al.
Publicado: (2023)

Striking Visualization of Diffuse Congenital Nesidioblastosis on Ga-68 DOTATATE PET/CT
por: Canbaz, Fevziye, et al.
Publicado: (2019)

Ga-68 DOTATATE PET/CT in a patient with Zollinger-Ellison syndrome
por: Jayasekera, Migara, et al.
Publicado: (2023)

Diagnostic challenges in a patient with an occult insulinoma:(68 )Ga‐DOTA‐exendin‐4 PET/CT and (68)Ga‐DOTATATE PET/CT
por: Bongetti, Elisa, et al.
Publicado: (2018)

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience
por: Elboga, Umut, et al.
Publicado: (2022)

Unusual Increased Blood Pool Activity on (68)Ga-DOTATATE PET/CT in a Patient With Metastatic Neuroendocrine Disease
por: Sharma, Akash, et al.
Publicado: (2022)

(68)Ga-DOTATATE PET/CT versus (111)In-octreotide scintigraphy in patients with neuroendocrine tumors: a prospective study
por: Cavicchioli, Marcelo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mq18gel0qsfdbbit7il1sbp6m4